Dr Patrick Reeves at the Massachusetts General Hospital is collaborating with ImmunoScape on a pilot study to evaluate flu-specific T cell responses induced in participants taking part in a clinical trial of FluGen’s novel M2SR influenza vaccine using mass cytometry.
MGH Collaboration
January 22, 2020